AI assistant
Sending…
Cencora, Inc. — Director's Dealing 2017
Dec 5, 2017
29973_dirs_2017-12-05_2847c06e-775f-48f8-a8a8-15b9846a60f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMERISOURCEBERGEN CORP (ABC)
CIK: 0001140859
Period of Report: 2017-12-04
Reporting Person: Guttman Tim G. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-04 | Common Stock | M | 5800 | $37.37 | Acquired | 56435.876 | Direct |
| 2017-12-04 | Common Stock | S | 5800 | $85.73 | Disposed | 50635.876 | Direct |
| 2017-12-04 | Common Stock | M | 5800 | $40.21 | Acquired | 56435.876 | Direct |
| 2017-12-04 | Common Stock | S | 5800 | $85.73 | Disposed | 50635.876 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-04 | Non-qualified Stock Option (Right to Buy) | $37.37 | M | 5800 | Disposed | 2019-03-01 | Common Stock (5800) | Direct |
| 2017-12-04 | Non-qualified Stock Option (Right to Buy) | $40.21 | M | 5800 | Disposed | 2019-11-14 | Common Stock (5800) | Direct |
Footnotes
F1: The exercise of stock options and the sale of common stock reflected in this Form 4 were pursuant to a Rule 10b-5 trading plan dated August 18, 2017 governing stock options scheduled to expire on March 1, 2019 and November 14, 2019.
F2: Exercisable in four equal annual installments on 03/01/13, 03/01/14, 03/01/15 and 03/01/2016
F3: Exercisable in four equal annual installments on 11/14/13, 11/14/14, 11/14/15 and 11/14/16
More from Cencora, Inc.
Board/Management Information
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 6
Major Shareholding Notification
2026
Mar 26
M&A Activity
2026
Mar 23
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 20
M&A Activity
2026
Feb 18